Pharmaceutical Outsourcing covers news of importance to the contract services segment of the pharmaceutical industry.
Collected from the most trusted on-line resources, these news stories are chosen and published here based on their relevance to the pharmaceutical industry.
Topics of interest typically include: mergers and acquisitions, service additions, new capabilities, personnel changes, news from the FDA and other international regulatory and standard-setting agencies, and new outsourcing contracts and deals.
If you are looking to stay up-to-date with the news in your industry, this resource is vital for your industry knowledge.
Tuesday, September 15, 2020
The two organizations form an agile and scalable consulting firm dedicated to their combined focus areas in the life science industry.
read more
Tuesday, September 15, 2020
CPO Tjoapack is investing in its automated packaging capabilities to meet growing customer demand for pre-filled syringes and vials.
read more
Tuesday, September 15, 2020
Cobra Biologics and CombiGene have signed agreements covering GMP production of two essential plasmids needed for the manufacture of a gene therapy for drug resistant focal epilepsy.
read more
Wednesday, September 16, 2020
Sai Life Sciences announced the addition of cellular analysis platforms at its Discovery Biology facility in Cambridge, Massachusetts, USA.
read more
Wednesday, September 16, 2020
Bio-Rad Laboratories announced the launch of StarBright Violet 515 Dye, the first of a new range of unique fluorescent nanoparticles, for use in flow cytometry.
read more
Wednesday, September 16, 2020
The FDA has issued a temporary guidance, “Resuming Normal Drug and Biologics Manufacturing Operations During the COVID-19 Public Health Emergency.”
read more
Wednesday, September 16, 2020
Vishnu Dwadasi has joined Pii as the head of the company’s Project Management Office.
read more
Wednesday, September 16, 2020
Valneva and Dynavax announced a commercial partnership for the supply of Dynavax's CpG 1018 adjuvant for use in Valneva's SARS-CoV-2 vaccine candidate, VLA2001.
read more
Wednesday, September 16, 2020
Gannex and Galmed have entered into a research agreement aiming at combination therapy of ASC41 and Aramchol for NASH.
read more
Friday, September 18, 2020
Arctoris has signed a Memorandum of Understanding with listed Korean company Syntekabio to collaborate on drug discovery efforts.
read more
Friday, September 18, 2020
Vectura has signed an agreement with Monash University’s Institute of Pharmaceutical Sciences to develop inhaled oxytocin to prevent postpartum haemorrhage.
read more
Friday, September 18, 2020
Thermo Fisher Scientific announced collaborations of the PMSC with AstraZeneca and the University of Nebraska Medical Center as part of development of solutions for biomarker discovery
read more
Friday, September 18, 2020
Moleculin Biotech has contracted with an independent laboratory to test the antiviral activity of its WP1122 portfolio in a COVID-19 animal model.
read more
Monday, September 21, 2020
Mylan and Pfizer announced the companies have received final approval from the EC for the proposed combination of Mylan and Pfizer's Upjohn business.
read more
Monday, September 21, 2020
BioNTech will receive a grant by the German Federal Ministry of Education and Research to support the accelerated development of SARS-CoV-2 vaccines.
read more